Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
Synta Pharma (SNTA) Prices 22M Common Offering at $1.75/Share
March 31, 2015 9:16 AM EDTSynta Pharma (NASDAQ: SNTA) has priced an underwritten public offering of 22,000,000 shares of its common stock at a price to the public of $1.75 per share. Gross proceeds to Synta are expected to be approximately $38.5 million, before deducting the underwriting discounts and commissions and... More
Synta Pharma (SNTA) to Offer Common Shares
March 30, 2015 4:02 PM EDTSynta Pharma (NASDAQ: SNTA) announced that it has commenced an underwritten public offering of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering... More
